Amret Hawfield

2.6k total citations
15 papers, 574 citations indexed

About

Amret Hawfield is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amret Hawfield has authored 15 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Nephrology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amret Hawfield's work include Blood Pressure and Hypertension Studies (7 papers), Chronic Kidney Disease and Diabetes (5 papers) and Renal Diseases and Glomerulopathies (3 papers). Amret Hawfield is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Chronic Kidney Disease and Diabetes (5 papers) and Renal Diseases and Glomerulopathies (3 papers). Amret Hawfield collaborates with scholars based in United States and Australia. Amret Hawfield's co-authors include Barry I. Freedman, Michael V. Rocco, Vijay Sharma, Manikkam Suthanthiran, Phyllis August, Cristina Sison, Uma Perni, Nicholas M. Pajewski, Anjay Rastogi and Joachim H. Ix and has published in prestigious journals such as Annals of Internal Medicine, Kidney International and Hypertension.

In The Last Decade

Amret Hawfield

15 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amret Hawfield United States 11 206 165 161 136 67 15 574
Kotaro Haruhara Japan 16 286 1.4× 149 0.9× 61 0.4× 182 1.3× 40 0.6× 73 696
Tomas Lenz Germany 12 51 0.2× 242 1.5× 149 0.9× 121 0.9× 47 0.7× 28 602
Yusuke Okabayashi Japan 14 301 1.5× 37 0.2× 60 0.4× 187 1.4× 31 0.5× 42 575
Fouad Amraoui Netherlands 10 49 0.2× 241 1.5× 64 0.4× 45 0.3× 45 0.7× 15 408
Gheorghe Gluhovschi Romania 16 416 2.0× 70 0.4× 24 0.1× 42 0.3× 49 0.7× 55 740
Tali Zitman‐Gal Israel 11 60 0.3× 41 0.2× 71 0.4× 38 0.3× 62 0.9× 40 401
Ioannis Petrakis Greece 13 231 1.1× 61 0.4× 21 0.1× 32 0.2× 58 0.9× 43 506
J. Silberbusch Netherlands 14 149 0.7× 87 0.5× 29 0.2× 39 0.3× 115 1.7× 40 704
Emily Robinson United States 9 106 0.5× 234 1.4× 29 0.2× 25 0.2× 14 0.2× 15 588
Florica Gădălean Romania 16 312 1.5× 58 0.4× 19 0.1× 31 0.2× 56 0.8× 73 646

Countries citing papers authored by Amret Hawfield

Since Specialization
Citations

This map shows the geographic impact of Amret Hawfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amret Hawfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amret Hawfield more than expected).

Fields of papers citing papers by Amret Hawfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amret Hawfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amret Hawfield. The network helps show where Amret Hawfield may publish in the future.

Co-authorship network of co-authors of Amret Hawfield

This figure shows the co-authorship network connecting the top 25 collaborators of Amret Hawfield. A scholar is included among the top collaborators of Amret Hawfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amret Hawfield. Amret Hawfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cushman, William C., Robert Ringer, Carlos J. Rodríguez, et al.. (2022). Blood Pressure Intervention and Control in SPRINT. Hypertension. 79(9). 2071–2080. 15 indexed citations
2.
Rocco, Michael V., Mary E. Comeau, Miranda C. Marion, et al.. (2020). Effects of Intensive Systolic Blood Pressure Control on All-Cause Hospitalizations. Hypertension. 76(6). 1717–1724. 2 indexed citations
3.
Potok, Onur, Joachim H. Ix, Michael G. Shlipak, et al.. (2020). The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). American Journal of Kidney Diseases. 76(6). 765–774. 78 indexed citations
4.
Garimella, Pranav S., Alexandra K. Lee, Walter T. Ambrosius, et al.. (2019). Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial. European Heart Journal. 40(42). 3486–3493. 50 indexed citations
5.
Hnı́zda, Aleš, Irène Ceballos-Picot, Amret Hawfield, et al.. (2018). Chronic tubulointerstitial kidney disease in untreated adenine phosphoribosyl transferase (APRT) deficiency: A case report. Clinical Nephrology. 90(4). 296–301. 6 indexed citations
6.
Shaltout, Hossam A., Joel Eggebeen, Anthony P. Marsh, et al.. (2017). Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction. Nitric Oxide. 69. 78–90. 53 indexed citations
7.
Freedman, Barry I., Michael V. Rocco, Jeffrey T. Bates, et al.. (2017). APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial. Kidney International Reports. 2(4). 713–720. 19 indexed citations
8.
Beddhu, Srinivasan, Michael V. Rocco, Robert D. Toto, et al.. (2017). Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease. Annals of Internal Medicine. 167(6). 375–383. 76 indexed citations
9.
Rocco, Michael V., Arlene B. Chapman, Glenn M. Chertow, et al.. (2016). Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions. American Journal of Nephrology. 44(2). 130–140. 11 indexed citations
10.
Langefeld, Carl D., Jasmin Divers, Nicholas M. Pajewski, et al.. (2014). Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney International. 87(1). 169–175. 57 indexed citations
11.
Hawfield, Amret, Samy S. Iskandar, & Richard J. Smith. (2013). Alternative Pathway Dysfunction in Kidney Disease: A Case Report and Review of Dense Deposit Disease and C3 Glomerulopathy. American Journal of Kidney Diseases. 61(5). 828–831. 7 indexed citations
12.
Perni, Uma, Cristina Sison, Vijay Sharma, et al.. (2012). Angiogenic Factors in Superimposed Preeclampsia. Hypertension. 59(3). 740–746. 106 indexed citations
13.
Bleyer, Anthony J. & Amret Hawfield. (2012). Modifiable risk factors for sudden death in dialysis patients. Nature Reviews Nephrology. 8(6). 323–324. 4 indexed citations
14.
Hawfield, Amret & Barry I. Freedman. (2008). Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Therapeutic Advances in Cardiovascular Disease. 3(1). 65–73. 59 indexed citations
15.
Hawfield, Amret, et al.. (2006). Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting. Critical Reviews in Oncology/Hematology. 59(3). 250–255. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kotaro Haruhara Breakdown of academic impact, for papers by Tomas Lenz Breakdown of academic impact, for papers by Yusuke Okabayashi Breakdown of academic impact, for papers by Fouad Amraoui Breakdown of academic impact, for papers by Gheorghe Gluhovschi Breakdown of academic impact, for papers by Tali Zitman‐Gal Breakdown of academic impact, for papers by Ioannis Petrakis Breakdown of academic impact, for papers by J. Silberbusch Breakdown of academic impact, for papers by Emily Robinson Breakdown of academic impact, for papers by Florica Gădălean
Rankless by CCL
2026